Risks After Denosumab Discontinuation Linked to Age and Prior Therapy
Age, treatment duration, and prior bisphosphonate therapy are all associated with potential bone mineral density (BMD) loss following the discontinuation of denosumab therapy, according to research published in Bone. Researchers...









